IA
IRMD icon

IFP Advisors’s iRadimed IRMD Stock Holding History

IFP Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15K Sell
156
-47
-23% -$4.7K ﹤0.01% 2937
2025
Q4 		$19.7K Sell
203
-24
-11% -$2.06K ﹤0.01% 2731
2025
Q3 		$16.2K Buy
227
+102
+82% +$6.8K ﹤0.01% 2693
2025
Q2 		$7.47K Buy
125
+58
+87% +$3.18K ﹤0.01% 3093
2025
Q1 		$3.52K Buy
67
+66
+6,600% +$3.71K ﹤0.01% 2965
2024
Q4 		$55 Buy
+1
New +$53 ﹤0.01% 4230
2017
Q4 		– Sell
-150
Closed -$1K – 3946
2017
Q3 		$1K Hold
150
– – ﹤0.01% 3914
2017
Q2 		$1K Buy
+150
New +$1.28K ﹤0.01% 3895

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IFP Advisors's IRMD Position: Q1 2026 in Review

IFP Advisors reduced its iRadimed (IRMD) stake by 23% in Q1 2026, selling an estimated $4.7K and leaving 156 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #2937.

IFP Advisors first reported a position in IRMD in Q2 2017 and has held it in 8 quarters since. The position peaked at $19.7K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • IFP Advisors held 156 shares of iRadimed worth $15K as of Q1 2026.
  • IFP Advisors sold 47 iRadimed shares in Q1 2026, an estimated $4.7K.
  • iRadimed made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #2937 holding.
  • IFP Advisors first reported a position in iRadimed in Q2 2017 and has held it in 8 quarters since.
  • IFP Advisors's iRadimed position peaked at $19.7K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.